MedPath
Found 6 clinical trials|View Analysis
Sort by:

Eculizumab for Acute Attack of Neuromyelitis Optica Spectrum Disorder

Phase 2
Not yet recruiting
Conditions
Neuromyelitis Optica Spectrum Disorder Attack
Interventions
Drug: IVMP
Drug: Complement protein C5 inhibitor
First Posted Date
2024-11-04
Last Posted Date
2024-11-04
Lead Sponsor
Tianjin Medical University General Hospital
Target Recruit Count
75
Registration Number
NCT06673394

Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Not yet recruiting
Conditions
Neuromyelitis Optica
Efgartigimod
Interventions
First Posted Date
2023-11-07
Last Posted Date
2023-11-07
Lead Sponsor
Feng Jinzhou
Target Recruit Count
24
Registration Number
NCT06118398

Liver Function After Intravenous Methylprednisolone Administration

Phase 4
Completed
Conditions
Liver Dysfunction
Acute Liver Failure
Methylprednisolone Adverse Reaction
Dysthyroid Ophthalmopathy
Liver Diseases
Liver Failure
Liver Injury
Liver Insufficiency
Glucocorticoids Toxicity
Graves Disease
Interventions
Drug: every week IVMP therapy
Drug: very high doses IVMP therapy
First Posted Date
2018-09-12
Last Posted Date
2018-09-13
Lead Sponsor
Medical University of Warsaw
Target Recruit Count
68
Registration Number
NCT03667157

Early PE for Autoimmune Encephalitis

Not Applicable
Completed
Conditions
Autoimmune Encephalitis
Interventions
First Posted Date
2018-05-31
Last Posted Date
2024-11-21
Lead Sponsor
Xuanwu Hospital, Beijing
Target Recruit Count
70
Registration Number
NCT03542279
Locations
🇨🇳

Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China

Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses

Not Applicable
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2013-07-16
Last Posted Date
2017-09-06
Lead Sponsor
Aaron Miller
Target Recruit Count
10
Registration Number
NCT01900093
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Preoperative Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass

Not Applicable
Completed
Conditions
Congenital Heart Disease
Disorder of Fetus or Newborn
Interventions
First Posted Date
2009-07-08
Last Posted Date
2011-12-09
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
77
Registration Number
NCT00934843
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath